%0 Journal Article
%T A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy: an editorial comment
%A Joyce Wong
%J Archive of "Annals of Translational Medicine".
%D 2019
%R 10.21037/atm.2019.01.75
%X Pancreatic cancer remains one of the most aggressive malignancies which has a mortality nearly parallel to incidence. In the United States, for example, statistics from the National Cancer Institute¡¯s Surveillance, Epidemiology, and End Results (SEER) Program estimates 55,440 new cases of pancreatic cancer in the U.S. in 2018, with 44,330 estimated deaths (1). Based on data collected from 2008¨C2014, only 8.5% of patients survive 5 years or longer (1). It is widely held that a combination of surgical resection and systemic chemotherapy provides the optimal treatment for pancreatic cancer. Unfortunately, only about 15¨C20% of patients present with resectable disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462598/